Neuraxis announces highmark bcbs policy coverage

Carmel, ind., march 11, 2024 (globe newswire) -- neuraxis, inc. (“neuraxis,” or the “company”) (nyse american: nrxs), a medical technology company commercializing neuromodulation therapies addressing chronic and debilitating conditions in children and adults, today announced receipt of highmark blue cross blue shield (“highmark bcbs”) policy coverage for approximately seven million lives effective april 8, 2024. highmark bcbs provides coverage in the mid-atlantic, covering pennsylvania, delaware, new york, and west virginia.
NRXS Ratings Summary
NRXS Quant Ranking